48-Week Outcome after Cessation of Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Patient and the Associated Factors with Relapse

Figure 3

Forty-eight-week cumulative rates of virologic relapse, clinical relapse, and retreatment.